Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Axonics, Inc.
< Previous
1
2
Next >
Axonics Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
May 16, 2024
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Reports First Quarter 2024 Financial Results
April 30, 2024
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Stockholders Approve Merger Agreement with Boston Scientific
March 22, 2024
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
March 14, 2024
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Responds to ITC Action by Medtronic
February 29, 2024
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 28, 2024
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
BSX
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Present at the J.P. Morgan Healthcare Conference
December 27, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Participate in November Investor Conferences
November 01, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Reports Third Quarter 2023 Financial Results
October 30, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Report Third Quarter 2023 Financial Results on October 30
October 02, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Participate in September Investor Conferences
August 25, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Announces CFO Retirement and Appoints Successor
August 21, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Reports Second Quarter 2023 Financial Results
July 27, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Report Second Quarter 2023 Financial Results on July 27
June 29, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Reports First Quarter 2023 Financial Results
May 01, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Participate in Upcoming Investor Conferences
April 25, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
April 24, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Report First Quarter 2023 Financial Results on May 1
April 10, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas
March 29, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Participate in the SUFU 2023 Winter Meeting
March 07, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Reports Fourth Quarter and Fiscal Year 2022 Financial Results
March 01, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Report Fourth Quarter 2022 Financial Results on March 1
February 08, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
January 31, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance
January 11, 2023
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
December 13, 2022
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
Axonics® to Participate in the Piper Sandler Healthcare Conference
November 18, 2022
From
Axonics, Inc.
Via
Business Wire
Tickers
AXNX
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit